Literature DB >> 22556403

Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.

S A Bhide1, K L Newbold, K J Harrington, C M Nutting.   

Abstract

Radiotherapy and surgery are the principal curative modalities in treatment of head and neck cancer. Conventional two-dimensional and three-dimensional conformal radiotherapy result in significant side effects and altered quality of life. Intensity-modulated radiotherapy (IMRT) can spare the normal tissues, while delivering a curative dose to the tumour-bearing tissues. This article reviews the current role of IMRT in head and neck cancer from the point of view of normal tissue sparing, and also reviews the current published literature by individual head and neck cancer subsites. In addition, we briefly discuss the role of image guidance in head and neck IMRT, and future directions in this area.

Entities:  

Mesh：

Year:  2012        PMID： 22556403      PMCID： PMC3479880          DOI： 10.1259/bjr/85942136

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  91 in total

1.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.

Authors:  A Eisbruch; R K Ten Haken; H M Kim; L H Marsh; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

Review 2.  Tolerance of normal tissue to therapeutic irradiation.

Authors:  B Emami; J Lyman; A Brown; L Coia; M Goitein; J E Munzenrider; B Shank; L J Solin; M Wesson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

3.  Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity.

Authors:  B Maciejewski; K Skladowski; B Pilecki; J M Taylor; R H Withers; L Miszczyk; A Zajusz; R Suwinski
Journal:  Radiother Oncol       Date:  1996-08       Impact factor: 6.280

4.  A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer.

Authors:  S M Jackson; L M Weir; J H Hay; V H Tsang; J S Durham
Journal:  Radiother Oncol       Date:  1997-04       Impact factor: 6.280

5.  Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

Authors:  Avraham Eisbruch; Marco Schwartz; Coen Rasch; Karen Vineberg; Eugene Damen; Corina J Van As; Robin Marsh; Frank A Pameijer; Alfons J M Balm
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

6.  Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.

Authors:  A Eisbruch; J A Ship; M K Martel; R K Ten Haken; L H Marsh; G T Wolf; R M Esclamado; C R Bradford; J E Terrell; S S Gebarski; A S Lichter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-09-01       Impact factor: 7.038

7.  Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.

Authors:  E B Butler; B S Teh; W H Grant; B M Uhl; R B Kuppersmith; J K Chiu; D T Donovan; S Y Woo
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-08-01       Impact factor: 7.038

8.  Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.

Authors:  Pia Huguenin; Karl T Beer; Abdelkarim Allal; Kaspar Rufibach; Corinne Friedli; Jacques Bernard Davis; Bernhard Pestalozzi; Stephan Schmid; Armin Thöni; Mahmut Ozsahin; Jacques Bernier; Michael Töpfer; Roger Kann; Urs Richard Meier; Peter Thum; Sabine Bieri; Markus Notter; Norbert Lombriser; Christoph Glanzmann
Journal:  J Clin Oncol       Date:  2004-11-08       Impact factor: 44.544

9.  Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.

Authors:  K S Clifford Chao; Gokhan Ozyigit; Angel I Blanco; Wade L Thorstad; Joseph O Deasy; Bruce H Haughey; Gershon J Spector; Donald G Sessions
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

10.  Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing.

Authors:  A Eisbruch; L H Marsh; M K Martel; J A Ship; R Ten Haken; A T Pu; B A Fraass; A S Lichter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-06-01       Impact factor: 7.038
View more
  24 in total

1.  Lipiodol injections for optimization of target volume delineation in a patient with a second tumor of the oropharynx: A case report.

Authors:  Marlen Haderlein; Ricarda Merten; Andrea Stojanovic; Stefan Speer; Claudia Scherl; Rainer Fietkau; Oliver J Ott
Journal:  Strahlenther Onkol       Date:  2015-06-04       Impact factor: 3.621

2.  Evaluation of an educational video to improve the understanding of radiotherapy side effects in head and neck cancer patients.

Authors:  Wilfredo Alejandro González-Arriagada; Marco Aurélio Carvalho de Andrade; Lara Maria Alencar Ramos; Jose Ribamar Sabino Bezerra; Alan Roger Santos-Silva; Marcio Ajudarte Lopes
Journal:  Support Care Cancer       Date:  2013-02-22       Impact factor: 3.603

Review 3.  [Tumors of the paranasal sinus invading the orbit].

Authors:  M Herzog
Journal:  HNO       Date:  2018-10       Impact factor: 1.284

4.  Tolerance of Chemoradiation in Advanced Head and Neck Cancers: Comparison Between Inpatients and Outpatients.

Authors:  Virender Suhag; B S Sunita; Pankaj Vats; N Chakravarty; Tejas Pandya; Nishant Lohia
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-10-06

5.  Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.

Authors: 
Journal:  Radiother Oncol       Date:  2016-02-17       Impact factor: 6.280

6.  Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study.

Authors:  Liam Welsh; Rafal Panek; Dualta McQuaid; Alex Dunlop; Maria Schmidt; Angela Riddell; Dow-Mu Koh; Simon Doran; Iain Murray; Yong Du; Sue Chua; Vibeke Hansen; Kee H Wong; Jamie Dean; Sarah Gulliford; Shreerang Bhide; Martin O Leach; Christopher Nutting; Kevin Harrington; Kate Newbold
Journal:  Radiat Oncol       Date:  2015-05-15       Impact factor: 3.481

7.  Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma - Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes.

Authors:  Marta Bogowicz; Matea Pavic; Oliver Riesterer; Tobias Finazzi; Helena Garcia Schüler; Edna Holz-Sapra; Leonie Rudofsky; Lucas Basler; Manon Spaniol; Andreas Ambrusch; Martin Hüllner; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

8.  Mechanism of the protective effect of phenylephrine pretreatment against irradiation-induced damage in the submandibular gland.

Authors:  Bin Xiang; Ya-Jie Li; Xi-Bo Zhao; Yang Zou; Zeng-Guo Yu; Yan-Ming Zhao; Fu-Yin Zhang
Journal:  Exp Ther Med       Date:  2012-12-19       Impact factor: 2.447

9.  Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.

Authors:  Rex H Lee; Hyunseok Kang; Sue S Yom; Agata Smogorzewska; Daniel E Johnson; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

10.  Interval between intra-arterial infusion chemotherapy and surgery for locally advanced oral squamous cell carcinoma: impacts on effectiveness of chemotherapy and on overall survival.

Authors:  Chih-Fung Wu; Chien-Hsing Lee; Edward Hsi; Chung-Ho Chen; Jen-Yang Tang
Journal:  ScientificWorldJournal       Date:  2014-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.